Allegria Therapeutics (ALLEGRIA), a Swiss biotech company redefining the treatment landscape of therapeutics for mast ...
Webinar to be held Tuesday, December 2nd, at 8:00 am ETREDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jasper ...
Mucosal surfaces serve as critical battlegrounds where the immune system must balance tolerance to commensal organisms with rapid defense against pathogens.
REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in preclinical models ...
News-Medical.Net on MSN
Unnecessary gluten-free diets may put children at risk
Understanding gluten-related disorders is crucial for pediatric nutrition, as gluten-free diets can pose health risks without ...
Hosted on MSN
Fungus in your nose could make your hay fever worse
That time of year is almost upon us, when millions of people in the UK succumb to pollen-induced sneezes, sniffles and itchy eyes: the dreaded hay fever. Now scientists may have identified a key ...
Jasper Therapeutics ( (JSPR) ) has provided an announcement.
Why do certain immune cells remain permanently active in allergic asthma – even in an environment that should actually damage them? A team from the University Hospital Bonn (UKB) and the University of ...
Mayo Clinic researchers have uncovered how aging "zombie cells" trigger harmful inflammation that accelerates a severe and ...
A patient with synovial sarcoma, a soft-tissue cancer that usually occurs in the large joints of the arms and legs, is the ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
Evommune, Inc. (NYSE: EVMN) (the "Company"), a clinical-stage biotechnology company developing innovative therapies that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback